Ng George K
SEC insider (Form 3/4/5 filer). CIK 0001638744. Chief Executive Officer at Processa Pharmaceuticals, Inc. (PCSA) and 1 other issuer. 20 reported Form 4/5 transactions since Sep 2024; latest on Aug 8, 2026. Located in VERO BEACH, FL.
Companies Ng George K has filed insider reports for
- Processa Pharmaceuticals, Inc. (PCSA): Director, Officer, Chief Executive Officer
- TuHURA Biosciences, Inc./NV (HURA): Director
Ng George K
CIK: 0001638744
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Aug 8, 2026PCSA
Processa Pharmaceuticals, Inc.
ExerciseDirect1.6K shares- - Jul 26, 2026PCSA
Processa Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
9.4K shares- - Jul 1, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect3.1K shares at avg. $1.93$6K - Jun 15, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect2.5K shares at avg. $2.22$5K - May 29, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect2.1K shares at avg. $2.57$5K - May 15, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect1.8K shares at avg. $2.97$5K - Apr 30, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect2K shares at avg. $2.69$5K - Apr 15, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect1.8K shares at avg. $2.97$5K - Mar 31, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect2.1K shares at avg. $2.54$5K - Feb 12, 2026HURA
TuHURA Biosciences, Inc./NV
AwardDirectOptions (Right to Buy)
156.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 8, 2026 |  PCSA Processa Pharmaceuticals, Inc. | Exercise | 1,600 | - | $0 | Direct |
| Jul 26, 2026 | PCSA Processa Pharmaceuticals, Inc. | Award Restricted Stock Units | 9,384 | - | - | Direct |
| Jul 1, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 3,057 | $1.93 | $5,900 | Direct |
| Jun 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 2,465 | $2.22 | $5,472 | Direct |
| May 29, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 2,129 | $2.57 | $5,472 | Direct |
| May 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,843 | $2.97 | $5,474 | Direct |
| Apr 30, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 2,034 | $2.69 | $5,471 | Direct |
| Apr 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,843 | $2.97 | $5,474 | Direct |
| Mar 31, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 2,136 | $2.54 | $5,415 | Direct |
| Feb 12, 2026 |  HURA TuHURA Biosciences, Inc./NV | Award Options (Right to Buy) | 156,240 | - | - | Direct |
1-10 of 20 transactions